- Home
- MRSN vs OXSQ Comparison
MRSN vs OXSQ Comparison
Compare MRSN & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- OXSQ
- Stock Information
- Founded
- MRSN 2001
- OXSQ 2003
- Country
- MRSN United States
- OXSQ United States
- Employees
- MRSN N/A
- OXSQ N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- OXSQ Blank Checks
- Sector
- MRSN Health Care
- OXSQ Finance
- Exchange
- MRSN Nasdaq
- OXSQ Nasdaq
- Market Cap
- MRSN 40.7M
- OXSQ 164.9M
- IPO Year
- MRSN 2017
- OXSQ N/A
- Fundamental
- Price
- MRSN $0.33
- OXSQ $2.33
- Analyst Decision
- MRSN Strong Buy
- OXSQ
- Analyst Count
- MRSN 5
- OXSQ 0
- Target Price
- MRSN $5.75
- OXSQ N/A
- AVG Volume (30 Days)
- MRSN 3.0M
- OXSQ 618.1K
- Earning Date
- MRSN 08-12-2025
- OXSQ 08-12-2025
- Dividend Yield
- MRSN N/A
- OXSQ 18.03%
- EPS Growth
- MRSN N/A
- OXSQ N/A
- EPS
- MRSN N/A
- OXSQ N/A
- Revenue
- MRSN $34,006,000.00
- OXSQ $42,166,831.00
- Revenue This Year
- MRSN N/A
- OXSQ N/A
- Revenue Next Year
- MRSN $1.03
- OXSQ N/A
- P/E Ratio
- MRSN N/A
- OXSQ N/A
- Revenue Growth
- MRSN N/A
- OXSQ N/A
- 52 Week Low
- MRSN $0.26
- OXSQ $2.14
- 52 Week High
- MRSN $2.83
- OXSQ $3.10
- Technical
- Relative Strength Index (RSI)
- MRSN 47.41
- OXSQ 58.38
- Support Level
- MRSN $0.27
- OXSQ $2.14
- Resistance Level
- MRSN $0.36
- OXSQ $2.32
- Average True Range (ATR)
- MRSN 0.03
- OXSQ 0.03
- MACD
- MRSN 0.00
- OXSQ 0.02
- Stochastic Oscillator
- MRSN 46.75
- OXSQ 90.00
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.